Back to results
US 2018/0022804 A1Published application
HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta)
AssigneeAerpio Therapeutics Inc.
InventorsKevin Peters, Michael Allen Flynn
Life of this patent
Estimating the term…
Abstract
The disclosure provides compositions and methods for the treatment of ocular conditions associated with angiogenesis comprising administering an antibody that targets a tyrosine phosphatase inhibitor in a subject.
Claims46
1-56. (canceled)
A compound comprising:
- a) a heavy chain that comprises a sequence that is at least 80% identical to SEQ ID NO:
- 30;
- and
- b) a light chain that comprises a sequence that is at least 80% identical to SEQ ID NO:
- 34.
2 more elements
70-95. (canceled)
A method of treating a condition in a subject in need thereof, the method comprising administering to the subject a therapeutically-effective amount of a compound, the compound comprising:
- a) a heavy chain that comprises a sequence that is at least 80% identical to SEQ ID NO:
- 30;
- and
- b) a light chain that comprises a sequence that is at least 80% identical to SEQ ID NO:
- 34.
2 more elements
Dependencies are inferred from the claim text.